Benjamin S. Szwergold

3.0k total citations
57 papers, 2.5k citations indexed

About

Benjamin S. Szwergold is a scholar working on Clinical Biochemistry, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Benjamin S. Szwergold has authored 57 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Clinical Biochemistry, 22 papers in Molecular Biology and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Benjamin S. Szwergold's work include Advanced Glycation End Products research (28 papers), Diet, Metabolism, and Disease (10 papers) and Biochemical effects in animals (9 papers). Benjamin S. Szwergold is often cited by papers focused on Advanced Glycation End Products research (28 papers), Diet, Metabolism, and Disease (10 papers) and Biochemical effects in animals (9 papers). Benjamin S. Szwergold collaborates with scholars based in United States, Australia and Denmark. Benjamin S. Szwergold's co-authors include Paul J. Beisswenger, Scott K. Howell, Truman R. Brown, Francis Kappler, Sundeep Lal, Michael Mauer, Robert G. Nelson, Robert Graham, Deborah A. Hogan and Matthew J. Wargo and has published in prestigious journals such as Science, Journal of Biological Chemistry and Diabetes Care.

In The Last Decade

Benjamin S. Szwergold

57 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin S. Szwergold United States 24 1.1k 811 776 666 291 57 2.5k
Jesús R. Requena Spain 20 1.1k 0.9× 512 0.6× 1.0k 1.3× 792 1.2× 265 0.9× 29 2.7k
Susan A. Phillips United States 25 729 0.6× 612 0.8× 1.3k 1.7× 1.4k 2.1× 237 0.8× 56 3.6k
Antony C. McLellan United Kingdom 11 1.3k 1.1× 485 0.6× 551 0.7× 630 0.9× 325 1.1× 16 1.8k
Arti Dhar India 21 506 0.4× 369 0.5× 654 0.8× 334 0.5× 203 0.7× 67 1.7k
Bendicht Wermuth Switzerland 28 704 0.6× 388 0.5× 1.3k 1.7× 443 0.7× 267 0.9× 92 3.0k
Gabriele V. Gnoni Italy 30 326 0.3× 450 0.6× 1.3k 1.6× 482 0.7× 98 0.3× 79 2.4k
Minako Imamura Japan 20 395 0.3× 554 0.7× 1.2k 1.5× 823 1.2× 116 0.4× 41 2.8k
F. Umeda Japan 17 434 0.4× 611 0.8× 855 1.1× 773 1.2× 106 0.4× 55 2.5k
B.J. Ortwerth United States 34 1.5k 1.3× 260 0.3× 2.2k 2.9× 969 1.5× 169 0.6× 115 3.2k
Carina Prip‐Buus France 34 640 0.6× 325 0.4× 2.1k 2.8× 776 1.2× 100 0.3× 64 3.4k

Countries citing papers authored by Benjamin S. Szwergold

Since Specialization
Citations

This map shows the geographic impact of Benjamin S. Szwergold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin S. Szwergold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin S. Szwergold more than expected).

Fields of papers citing papers by Benjamin S. Szwergold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin S. Szwergold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin S. Szwergold. The network helps show where Benjamin S. Szwergold may publish in the future.

Co-authorship network of co-authors of Benjamin S. Szwergold

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin S. Szwergold. A scholar is included among the top collaborators of Benjamin S. Szwergold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin S. Szwergold. Benjamin S. Szwergold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Szwergold, Benjamin S.. (2017). Reactions between methylglyoxal and its scavengers in-vivo appear to be catalyzed enzymatically. Medical Hypotheses. 109. 153–155. 4 indexed citations
3.
Maue, Robert A., Robert W. Burgess, Bing Wang, et al.. (2011). A novel mouse model of Niemann–Pick type C disease carrying a D1005G-Npc1 mutation comparable to commonly observed human mutations. Human Molecular Genetics. 21(4). 730–750. 103 indexed citations
4.
5.
Szwergold, Benjamin S., Scott K. Howell, & Paul J. Beisswenger. (2005). Transglycation—A Potential New Mechanism for Deglycation of Schiff's Bases. Annals of the New York Academy of Sciences. 1043(1). 845–864. 23 indexed citations
6.
Szwergold, Benjamin S.. (2005). Carnosine and anserine act as effective transglycating agents in decomposition of aldose-derived Schiff bases. Biochemical and Biophysical Research Communications. 336(1). 36–41. 51 indexed citations
7.
8.
Beisswenger, Paul J., et al.. (2005). Some Clues as to the Regulation, Expression, Function, and Distribution of Fructosamine‐3‐Kinase and Fructosamine‐3‐Kinase‐Related Protein. Annals of the New York Academy of Sciences. 1043(1). 824–836. 26 indexed citations
9.
Beisswenger, Paul J., et al.. (2004). The expression of the genes for fructosamine-3-kinase and fructosamine-3-kinase-related protein appears to be constitutive and unaffected by environmental signals. Biochemical and Biophysical Research Communications. 323(3). 932–936. 23 indexed citations
10.
Beisswenger, Paul J., Scott K. Howell, Kenneth E. Smith, & Benjamin S. Szwergold. (2003). Glyceraldehyde-3-phosphate dehydrogenase activity as an independent modifier of methylglyoxal levels in diabetes. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1637(1). 98–106. 109 indexed citations
11.
Szwergold, Benjamin S., Scott K. Howell, & Paul J. Beisswenger. (2002). Nonenzymatic glycation/enzymatic deglycation: a novel hypothesis on the etiology of diabetic complications. International Congress Series. 1245. 143–152. 12 indexed citations
12.
Beisswenger, Paul J., et al.. (1999). Metformin reduces systemic methylglyoxal levels in type 2 diabetes.. Diabetes. 48(1). 198–202. 363 indexed citations
13.
Lal, Sundeep, William C. Randall, Francis Kappler, et al.. (1997). Fructose-3-phosphate production and polyol pathway metabolism in diabetic rat hearts. Metabolism. 46(11). 1333–1338. 28 indexed citations
14.
Lal, Sundeep, et al.. (1995). Production of fructose and fructose-3-phosphate in maturing rat lenses.. PubMed. 36(5). 969–73. 21 indexed citations
15.
Szwergold, Benjamin S., et al.. (1995). Properties of Fructose-1,6-Bisphosphate Aldolase from Escherichia coli: An NMR Analysis. Archives of Biochemistry and Biophysics. 317(1). 244–252. 16 indexed citations
16.
Lal, Sundeep, Benjamin S. Szwergold, Francis Kappler, & Truman R. Brown. (1993). Detection of fructose-3-phosphokinase activity in intact mammalian lenses by 31P NMR spectroscopy.. Journal of Biological Chemistry. 268(11). 7763–7767. 28 indexed citations
17.
Szwergold, Benjamin S.. (1992). NMR Spectroscopy of Cells. Annual Review of Physiology. 54(1). 775–798. 50 indexed citations
18.
Petersen, Anja Sofie, Benjamin S. Szwergold, Francis Kappler, Michael Weingarten, & Truman R. Brown. (1990). Identification of sorbitol 3-phosphate and fructose 3-phosphate in normal and diabetic human erythrocytes.. Journal of Biological Chemistry. 265(29). 17424–17427. 35 indexed citations
19.
Szwergold, Benjamin S., Truman R. Brown, & Jerome J. Freed. (1989). Bicarbonate abolishes intracellular alkalinization in mitogen‐stimulated 3T3 cells. Journal of Cellular Physiology. 138(2). 227–235. 20 indexed citations
20.
Szwergold, Benjamin S., Truman R. Brown, & Jerome J. Freed. (1988). Bicarbonate Abolishes Intracellular Alkalinization in Mitogen‐Stimulated NIH 3T3 Cells. Annals of the New York Academy of Sciences. 551(1). 277–279. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jesús R. Requena Breakdown of academic impact, for papers by Susan A. Phillips Breakdown of academic impact, for papers by Antony C. McLellan Breakdown of academic impact, for papers by Arti Dhar Breakdown of academic impact, for papers by Bendicht Wermuth Breakdown of academic impact, for papers by Gabriele V. Gnoni Breakdown of academic impact, for papers by Minako Imamura Breakdown of academic impact, for papers by F. Umeda Breakdown of academic impact, for papers by B.J. Ortwerth Breakdown of academic impact, for papers by Carina Prip‐Buus
Rankless by CCL
2026